Literature DB >> 6626001

Retinocytoma. A benign variant of retinoblastoma.

C Margo, A Hidayat, J Kopelman, L E Zimmerman.   

Abstract

Six examples of a distinctive benign retinal tumor, occurring in five children and treated only by enucleation, were studied by light and electron microscopy and tested for S-100 protein, a glial-cell tissue marker. The small placoid, noninvasive lesions were composed entirely of benign-appearing cells with numerous fleurettes. These tumors showed no necrosis or mitotic activity. Ultrastructurally, they were composed predominantly of neuronal cells exhibiting photoreceptor differentiation. Some tumor cells had cytologic features of Müller's fibers and other glial cells that in one lesion stained positively for S-100 protein. In two patients there was a family history of retinoblastoma. All children were alive and well at follow-up examinations conducted three to 14 years after enucleation. To expand our concept of retinoblastoma to include this benign variant, we propose the term "retinocytoma." Although clinically and morphologically distinct from retinoblastoma, retinocytoma should carry the same genetic implication as its malignant counterpart.

Entities:  

Mesh:

Year:  1983        PMID: 6626001     DOI: 10.1001/archopht.1983.01040020521003

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  14 in total

1.  Two masquerade presentations of retinoblastoma.

Authors:  Andrea Lembo; Francesco Pichi; Elisabetta Santangelo; Paola Carrai; Theodora Hadjistilianou; Massimiliano Serafino; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2015-10-08       Impact factor: 2.031

2.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

3.  Müller cell alterations from long-term ambient fluorescent light exposure in monkeys: light and electron microscopic, fluorescein and lipofuscin study.

Authors:  D K Berler
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 4.  Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.

Authors:  Michelle G Zhang; John Y Lee; Ryan A Gallo; Wensi Tao; David Tse; Ravi Doddapaneni; Daniel Pelaez
Journal:  Pharmacol Res       Date:  2017-12-02       Impact factor: 7.658

5.  Neurocytoma of the retina.

Authors:  C Metcalf; E M Mele; I McAllister
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

Review 6.  [Retinoblastoma and retinocytoma (retinoma)].

Authors:  K A Metz; D Westerwick; F Driever; K W Schmid; C H D Le Guin
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

7.  Retinocytoma associated with bilateral retinoblastoma.

Authors:  Masood Naseripour; Khalil Ghasemi Falavarjani; Siamak Akbarzadeh
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

Review 8.  Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma.

Authors:  F Gonzalez-Fernandez; M B Lopes; J M Garcia-Fernandez; R G Foster; W J De Grip; S Rosemberg; S A Newman; S R VandenBerg
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

9.  Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis.

Authors:  Hana Abouzeid; Daniel F Schorderet; Aubin Balmer; Francis L Munier
Journal:  Mol Vis       Date:  2009-04-17       Impact factor: 2.367

10.  A new rosette in retinoblastoma.

Authors:  Dipankar Das; Kasturi Bhattacharjee; Sumita Sarma Barthakur; Prerana Sushil Tahiliani; Panna Deka; Harsha Bhattacharjee; Apurba Deka; Rajashree Paul
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.